Sample result
A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.
GLP-1, a diabetes hormone
Protein → Patent proteins · Automatic (Smith-Waterman)
Every list and the search record, one sheet each.
- Query
- GLP-1 · 31 lettersHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG
- Set
- Public patent sequences: Patent proteins, snapshot 2026-11-05-c456f6bdba29
- Ran
- 2026-11-12
- Found
- 5,000 sequences, 3,061 publications, 1,851 families
Charts
Identity against coverage
5,000 hits by identity and query coverage. 5,000 with a date.
Show table
| Band | Has a date | All |
|---|---|---|
| 100% | 553 | 553 |
| 95 to 99.9% | 992 | 992 |
| 90 to 94.9% | 2,638 | 2,638 |
| 80 to 89.9% | 814 | 814 |
| 70 to 79.9% | 3 | 3 |
| Band | Has a date | All |
|---|---|---|
| 100% | 3,606 | 3,606 |
| 95 to 99.9% | 876 | 876 |
| 90 to 94.9% | 483 | 483 |
| 80 to 89.9% | 35 | 35 |
Hits by year
3,061 publications by year of first publication, 1990 to 2026.
Show table
| Year | Has a date | All |
|---|---|---|
| 1990 | 2 | 2 |
| 1992 | 2 | 2 |
| 1993 | 1 | 1 |
| 1994 | 1 | 1 |
| 1995 | 1 | 1 |
| 1996 | 3 | 3 |
| 1997 | 2 | 2 |
| 1998 | 2 | 2 |
| 1999 | 11 | 11 |
| 2000 | 13 | 13 |
| 2001 | 20 | 20 |
| 2002 | 37 | 37 |
| 2003 | 33 | 33 |
| 2004 | 37 | 37 |
| 2005 | 54 | 54 |
| 2006 | 62 | 62 |
| 2007 | 77 | 77 |
| 2008 | 81 | 81 |
| 2009 | 107 | 107 |
| 2010 | 101 | 101 |
| 2011 | 110 | 110 |
| 2012 | 121 | 121 |
| 2013 | 123 | 123 |
| 2014 | 135 | 135 |
| 2015 | 142 | 142 |
| 2016 | 144 | 144 |
| 2017 | 157 | 157 |
| 2018 | 149 | 149 |
| 2019 | 150 | 150 |
| 2020 | 156 | 156 |
| 2021 | 183 | 183 |
| 2022 | 161 | 161 |
| 2023 | 175 | 175 |
| 2024 | 181 | 181 |
| 2025 | 231 | 231 |
| 2026 | 96 | 96 |
Where hits align on the query
The top 20 hits on GLP-1, a query of 31 amino acids: 20 cover the whole query, none differs from it.
Show table
| Hit | Query from | Query to | Identity | Differs at | Gaps at | X at |
|---|---|---|---|---|---|---|
| AAA55132.1 | 1 | 31 | 100.0% | None | None | None |
| A31422.1 | 1 | 31 | 100.0% | None | None | None |
| AAB11984.1 | 1 | 31 | 100.0% | None | None | None |
| DI506186 | 1 | 31 | 100.0% | None | None | None |
| DI527435 | 1 | 31 | 100.0% | None | None | None |
| AAB11995.1 | 1 | 31 | 100.0% | None | None | None |
| AAE02614.1 | 1 | 31 | 100.0% | None | None | None |
| DI540976 | 1 | 31 | 100.0% | None | None | None |
| DI521338 | 1 | 31 | 100.0% | None | None | None |
| DI502216 | 1 | 31 | 100.0% | None | None | None |
| DJ789879 | 1 | 31 | 100.0% | None | None | None |
| DI520483 | 1 | 31 | 100.0% | None | None | None |
| AAE49428.1 | 1 | 31 | 100.0% | None | None | None |
| AAE49430.1 | 1 | 31 | 100.0% | None | None | None |
| AAE49429.1 | 1 | 31 | 100.0% | None | None | None |
| AAE49432.1 | 1 | 31 | 100.0% | None | None | None |
| DI501808 | 1 | 31 | 100.0% | None | None | None |
| AAY78103.1 | 1 | 31 | 100.0% | None | None | None |
| BD613525 | 1 | 31 | 100.0% | None | None | None |
| BD613528 | 1 | 31 | 100.0% | None | None | None |
Patents 3.1K
3,061 publications from 692 applicants, 83 with no applicant, match these filters.
Amylin Pharmaceuticals, Inc. 78 publications, continued
-
US 6902744-A2005-06-07
Exendin agonist formulations and methods of administration thereof
Amylin Pharmaceuticals, Inc.
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
JP 2006514035-A2006-04-27
PREVENTION AND TREATMENT OF CARDIAC ARRHYTHMIAS
AMYLIN PHARMACEUTICALS INC
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
US 7157555-A2007-01-02
Exendin agonist compounds
Amylin Pharmaceuticals, Inc.
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
WO 2007024700-A22007-03-01
Exendin for treating diabetes and reducing body weight
AMYLIN PHARMACEUTICALS, INC. (US)
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
US 7220721-A2007-05-22
Exendin agonist peptides
Amylin Pharmaceuticals, Inc.
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
US 7223725-A2007-05-29
Exendin agonist compounds
Amylin Pharmaceuticals, Inc.
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
WO 2008005527-A2008-01-10
Glucagon-like peptides and uses thereof
Amylin Pharmaceuticals, Inc. (US)
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
EP 1938830-A12008-07-02
Novel exendin agonist compounds
AMYLIN PHARMACEUTICALS, INC. (US)
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
EP 1938831-A12008-07-02
Novel exendin agonist compounds
AMYLIN PHARMACEUTICALS, INC. (US)
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
EP 1941900-A12008-07-09
Novel exendin agonist compounds
AMYLIN PHARMACEUTICALS, INC. (US)
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
JP 2008530130-A2008-08-07
GIP ANALOG AND HYBRID POLYPEPTIDES WITH SELECTABLE PROPERTIES
AMYLIN PHARMACEUTICALS INC
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
US 7442680-A2008-10-28
Inotropic and diuretic effects of GLP-1 and GLP-1 agonists
Amylin Pharmaceuticals, Inc.
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
JP 2010500996-A2010-01-14
DPP-IV RESISTANT GIP HYBRID POLYPEPTIDES WITH SELECTABLE PROPERTIES
AMYLIN PHARMACEUTICALS INC
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
US 7696161-B22010-04-13
Exendin agonist compounds
Amylin Pharmaceuticals, Inc.
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
US 7790681-B22010-09-07
Treatment of cardiac arrhythmias with GLP-1 receptor ligands
Amylin Pharmaceuticals, Inc.
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
EP 2303313-A22011-04-06
EXENDINS TO LOWER CHOLESTROL AND TRIGLYCERIDES
AMYLIN PHARMACEUTICALS INC
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
US 7928065-B22011-04-19
Methods of treatment using exendin peptides or GLP-1 peptides
Amylin Pharmaceuticals, Inc.
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
EP 2347762-A12011-07-27
Exendin for treating diabetes and reducing body weight
AMYLIN PHARMACEUTICALS INC
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
EP 2392595-A12011-12-07
GIP analog and hybrid polypeptides with selectable properties
AMYLIN PHARMACEUTICALS INC
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
US 8263545-B22012-09-11
GIP analog and hybrid polypeptides with selectable properties
Amylin Pharmaceuticals, Inc.
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
US 8263550-B22012-09-11
Exendin agonist compounds
Amylin Pharmaceuticals, Inc.
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
US 8329648-B22012-12-11
Methods for treating diabetes and reducing body weight
Amylin Pharmaceuticals, LLC
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
US 8404637-B22013-03-26
GIP analog and hybrid polypeptides with selectable properties
Amylin Pharmaceuticals, LLC
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
JP 2014058528-A2014-04-03
DPP-IV RESISTANT GIP HYBRID POLYPEPTIDES WITH SELECTABLE PROPERTIES
AMYLIN PHARMACEUTICALS INC
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
EP 2841090-A12015-03-04
SITE-SPECIFIC ENZYMATIC MODIFICATION OF EXENDINS AND ANALOGS THEREOF
AMYLIN PHARMACEUTICALS LLC
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
EP 3524261-A12019-08-14
EXENDIN FOR TREATING DIABETES AND REDUCING BODY WEIGHT
AMYLIN PHARMACEUTICALS LLC
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
EP 1419783-A22004-05-19
Use of a composition comprising an exendin or a compound derived therefrom and a pharmaceutical carrier
AMYLIN PHARMACEUTICALS, INC. (US)
Query Match 95.7%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||| ||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAALEFIAWLVKGRG 3130 of 31 identical, no gaps.
-
WO 2007022123-A22007-02-22
Hybrid polypeptides with selectable properties
AMYLIN PHARMACEUTICALS, INC. (US)
Query Match 93.8%Identity 96.7%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 || |||||||||||||||| ||||||||||| Hit 1 HAQGTFTSDVSSYLEGQAALEFIAWLVKGRG 3129 of 31 identical, no gaps.
-
JP 2007525495-A2007-09-06
HYBRID POLYPEPTIDES WITH SELECTABLE PROPERTIES
AMYLIN PHARMACEUTICALS INC
Query Match 93.8%Identity 96.7%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 || |||||||||||||||| ||||||||||| Hit 1 HAQGTFTSDVSSYLEGQAALEFIAWLVKGRG 3129 of 31 identical, no gaps.
-
JP 2011219488-A2011-11-04
HYBRID POLYPEPTIDES WITH SELECTABLE PROPERTIES
AMYLIN PHARMACEUTICALS INC
Query Match 93.8%Identity 96.7%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 || |||||||||||||||| ||||||||||| Hit 1 HAQGTFTSDVSSYLEGQAALEFIAWLVKGRG 3129 of 31 identical, no gaps.
-
JP 2011246468-A2011-12-08
HYBRID POLYPEPTIDES WITH SELECTABLE PROPERTIES
AMYLIN PHARMACEUTICALS INC
Query Match 93.8%Identity 96.7%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 || |||||||||||||||| ||||||||||| Hit 1 HAQGTFTSDVSSYLEGQAALEFIAWLVKGRG 3129 of 31 identical, no gaps.
-
US 8076288-B22011-12-13
Hybrid polypeptides having glucose lowering activity
Amylin Pharmaceuticals, Inc.
Query Match 93.8%Identity 96.7%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 || |||||||||||||||| ||||||||||| Hit 1 HAQGTFTSDVSSYLEGQAALEFIAWLVKGRG 3129 of 31 identical, no gaps.
-
EP 2417980-A12012-02-15
Hybrid polypeptides with selectable properties
AMYLIN PHARMACEUTICALS INC
Query Match 93.8%Identity 96.7%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 || |||||||||||||||| ||||||||||| Hit 1 HAQGTFTSDVSSYLEGQAALEFIAWLVKGRG 3129 of 31 identical, no gaps.
-
JP 2002509078-A2002-03-26
Inotropic and diuretic effects of exendin and GLP-1
AMYLIN PHARMACEUTICALS INC
Query Match 93.2%Identity 100.0%
Best alignment
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29 ||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 2929 of 29 identical, no gaps.
-
KR 1020140011431-A2014-01-28
HYBRID POLYPEPTIDES WITH SELECTABLE PROPERTIES
Amylin Pharmaceuticals, LLC.
Query Match 93.2%Identity 96.7%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 || |||||||||||||||| ||||||||||| Hit 1 HAKGTFTSDVSSYLEGQAALEFIAWLVKGRG 3129 of 31 identical, no gaps.
BIONEBRASKA, INC. (US) 12 publications
-
WO 0066138-A22000-11-09
Metabolic intervention with glp-1 to improve the function of ischemic and reperfused tissue
BIONEBRASKA, INC. (US)
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 0066142-A22000-11-09
Metabolic intervention with glp-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain
BIONEBRASKA, INC. (US)
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 0077039-A22000-12-21
Glp-1 as a diagnostic test to determine _g(b)-cell function and the presence of the condition of igt and type-ii diabetes
BIONEBRASKA, INC. (US)
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 0187322-A22001-11-22
Peptide pharmaceutical formulations
BIONEBRASKA, INC. (US)
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
WO 0189554-A22001-11-29
Treatment of acute coronary syndrome with glp-1
BIONEBRASKA, INC. (US)
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 6344180-A2002-02-05
GLP-1 as a diagnostic test to determine .beta.-cell function and the presence of the condition of IGT and type II diabetes
BioNebraska, Inc.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 6429197-A2002-08-06
Metabolic intervention with GLP-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain
Bionebraska, Inc.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2002543142-A2002-12-17
Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue
BIONEBRASKA INC
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2002543145-A2002-12-17
Metabolism intervention using GLP-1 or its biologically-active analog for improving brain function in ischemia and reperfusion injury
BIONEBRASKA INC
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2003502344-A2003-01-21
GLP-1 as diagnostic and examination reagent for judging beta-cell function and the presence of IGT diseases and type II diabetes
BIONEBRASKA INC
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2002529101-A2002-09-10
Enzymatic amidation of peptides
BIONEBRASKA INC
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
US 6461834-A2002-10-08
Clostripain catalyzed amidation of peptides
Bionebraska, Inc.
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
Conjuchem, Inc. 23 publications
-
WO 0069900-A22000-11-23
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
Conjuchem, Inc. (CA)
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 7 to 37. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3731 of 31 identical, no gaps.
-
WO 0069911-A12000-11-23
Long lasting insulinotropic peptides
Conjuchem, Inc. (CA)
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 6329336-A2001-12-11
Long lasting insulinotropic peptides
Conjuchem, Inc.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.